Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Psychopharmacology

• Publication date

  1995-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF02245250PMID 7597123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence

  2005cited by this paper
• Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal

  2005cited by this paper
• Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test

  2005cited by this paper
• Effects of the 5-HT3 antagonist ondansetron on benzodiazepine-induced operant behavioural dependence in rats

  2005cited by this paper
• Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal

  2005cited by this paper
• Diazepam withdrawal responses measured in the social interaction test of anxiety and their reversal by baclofen

  2005cited by this paper
• Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment

  2004cited by this paper
• Assessment of the benzodiazepine‐like dependence potential in rats of the putative 5‐HT1A agonist anxiolytic S‐20499

  1994cited by this paper
• Assessment of the dependence potential of the potent high-efficacy 5-HT1A agonist S-14506 in rats

  1994cited by this paper
• Diazepam withdrawal: effects of diazepam and gepirone on acoustic startle-induced 22 kHz ultrasonic vocalizations

  1994cited by this paper
• Ethanol- and diazepam-withdrawal hyperlocomotion is not due to 5-HT3 receptor stimulation.

  1993cited by this paper
• Actions of ritanserin, a 5‐HT2/1C antagonist, in benzodiazepine‐dependent rats

  1993cited by this paper
• The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.

  1993influential reference
• Evidence for a dissociation between benzodiazepine withdrawal signs.

  1993cited by this paper
• Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.

  1993cited by this paper
• The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI‐988

  1992cited by this paper
• Effects of the 5‐HT3 antagonist ICS 205‐930 on benzodiazepine withdrawal signs in rats1

  1992cited by this paper
• Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.

  1992cited by this paper
• Ritanserin overcomes exploratory inhibition induced by cocaine withdrawal

  1992cited by this paper
• Effects of the 5-HT3 antagonist ICS 205-930 on benzodiazepine withdrawal signs in rats1

  1992cited by this paper
• Cholecystokinin antagonists.

  1991influential reference
• The behavioural properties of CI‐988, a selective cholecystokininB receptor antagonist

  1991cited by this paper
• Effects of the 5HT(1A) agonist anxiolytic gepirone on benzodiazepine withdrawal signs in rats.

  1991cited by this paper
• Sulfhydryl reducing agents distinguish two subtypes of angiotensin II receptors in the rat brain.

  1991cited by this paper
• Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.

  1991cited by this paper
• Evaluation of the effects of PD 134308 (CI-988), a CCK-B antagonist, on the punished responding of squirrel monkeys.

  1991cited by this paper
• 'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

  1991cited by this paper
• The effects of umespirone as a potential anxiolytic and antipsychotic agent.

  1991cited by this paper
• Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.

  1990cited by this paper
• The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.

  1990cited by this paper
• The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse

  1990cited by this paper
• Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

  1990cited by this paper
• Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset.

  1990cited by this paper
• Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain.

  1990cited by this paper
• Cholecystokinin and anxiety.

  1990cited by this paper
• Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics.

  1990cited by this paper
• The effects of ondansetron (GR38032F) in rats and mice treated subchronically with diazepam.

  1989cited by this paper
• A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.

  1989cited by this paper
• Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.

  1989cited by this paper
• Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor.

  1988cited by this paper
• Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

  1984cited by this paper

• The plastic phenomenon underlying the associative processes in the addictive properties of diazepam and other psychoactive drugs.

  2009cites this paper
• Participation of dorsal raphe nucleus in the behavioral alteration observed after discontinuation of chronic diazepam administration: Possible neural circuitry involved

  2005cites this paper
• The new antiepileptic drug levetiracetam normalises chlordiazepoxide withdrawal-induced anxiety in mice.

  2002cites this paper
• The experimental pharmacotherapy of benzodiazepine withdrawal.

  2002cites this paper
• Hippocampus and locus coeruleus activity on rats chronically treated with diazepam.

  2001cites this paper
• NMDA receptor antagonists potently suppress the spontaneous withdrawal signs induced by discontinuation of long-term diazepam treatment in Fischer 344 rats.

  1998cites this paper
• [Benzodiazepine withdrawal presenting as pseudo-surgical abdominal pain].

  1997cites this paper
• The CCK‐B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle

  1996cites this paper